Literature DB >> 25030183

Does vitamin D protect against respiratory viral infections?

K J Bryson1, A A Nash1, M Norval2.   

Abstract

The active form of vitamin D has effects on both innate and adaptive immune responses that may influence the outcome in many infectious diseases. Observational studies conclusively show that a low vitamin D status is associated with an increased occurrence of respiratory viral infections, which globally represent significant health and financial burdens. However, no consistent protective effects are evident in prospective clinical trials carried out to date where vitamin D was provided as a dietary supplement, except possibly in cases where the starting vitamin D status of the individual was considered deficient. Thus far, vitamin D has not been found to enhance the immune response to vaccines. The design of future prospective clinical trials assessing a role for vitamin D in respiratory viral infections requires very careful planning to avoid the uncertainties associated with the data available currently.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030183      PMCID: PMC9151239          DOI: 10.1017/S0950268814000193

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  69 in total

1.  TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.

Authors:  Elena Y Enioutina; Diana Bareyan; Raymond A Daynes
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

Review 2.  Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

Authors:  Prue H Hart; Shelley Gorman; John J Finlay-Jones
Journal:  Nat Rev Immunol       Date:  2011-08-19       Impact factor: 53.106

3.  Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults.

Authors:  Curtis Cooper; Anona Thorne
Journal:  HIV Clin Trials       Date:  2011 Sep-Oct

4.  A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol.

Authors:  S M Moe; M Zekonis; J Harezlak; W T Ambrosius; C M Gassensmith; C L Murphy; R R Russell; T D Batiuk
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

5.  Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling.

Authors:  Danny Bruce; Sanhong Yu; Jot Hui Ooi; Margherita T Cantorna
Journal:  Int Immunol       Date:  2011-06-22       Impact factor: 4.823

6.  The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases.

Authors:  Abdelhamid S Najada; Moen S Habashneh; Maher Khader
Journal:  J Trop Pediatr       Date:  2004-12       Impact factor: 1.165

7.  Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals.

Authors:  A-L Khoo; L Y A Chai; H J P M Koenen; F C G J Sweep; I Joosten; M G Netea; A J A M van der Ven
Journal:  Clin Exp Immunol       Date:  2011-02-16       Impact factor: 4.330

8.  Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals.

Authors:  Florence Momplaisir; Ian Frank; Wa Meyer; Deborah Kim; Rosemary Kappes; Pablo Tebas
Journal:  J AIDS Clin Res       Date:  2012-05-20

9.  The role of season in the epidemiology of influenza.

Authors:  R E Hope-Simpson
Journal:  J Hyg (Lond)       Date:  1981-02

10.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

Authors:  Menno D de Jong; Cameron P Simmons; Tran Tan Thanh; Vo Minh Hien; Gavin J D Smith; Tran Nguyen Bich Chau; Dang Minh Hoang; Nguyen Van Vinh Chau; Truong Huu Khanh; Vo Cong Dong; Phan Tu Qui; Bach Van Cam; Do Quang Ha; Yi Guan; J S Malik Peiris; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar
Journal:  Nat Med       Date:  2006-09-10       Impact factor: 53.440

View more
  9 in total

1.  Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection.

Authors:  Edwin Hoe; Jordan Nathanielsz; Zheng Quan Toh; Leena Spry; Rachel Marimla; Anne Balloch; Kim Mulholland; Paul V Licciardi
Journal:  Nutrients       Date:  2016-12-12       Impact factor: 5.717

Review 2.  Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data.

Authors:  Lars Rejnmark; Lise Sofie Bislev; Kevin D Cashman; Gudny Eiríksdottir; Martin Gaksch; Martin Grübler; Guri Grimnes; Vilmundur Gudnason; Paul Lips; Stefan Pilz; Natasja M van Schoor; Mairead Kiely; Rolf Jorde
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

Review 3.  The Role of Herbal and Nutritional Treatments in the Fight against COVID-19 and Other Respiratory Tract Infections.

Authors:  Aline El Zakhem; May Annie Chalhoub; Maya Bassil
Journal:  Int J Environ Res Public Health       Date:  2021-11-16       Impact factor: 3.390

4.  Association of vitamin D status with COVID-19 disease severity in pediatric patients: A retrospective observational study.

Authors:  Solmaz Heidari; Shooka Mohammadi; Mohammadreza Fathi; Shayan Cigary; Mohsen Alisamir; Mohammadreza Mirkarimi; Majid Aminzadeh
Journal:  Health Sci Rep       Date:  2022-04-06

Review 5.  Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease.

Authors:  Casey A Hribar; Peter H Cobbold; Frank C Church
Journal:  Brain Sci       Date:  2020-05-08

Review 6.  Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes.

Authors:  Choongho Lee
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

Review 7.  Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease.

Authors:  Kishalay Paria; Debarati Paul; Trinath Chowdhury; Smritikana Pyne; Ranadhir Chakraborty; Santi M Mandal
Journal:  Transl Med Commun       Date:  2020-11-05

8.  A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).

Authors:  Sajad Karampoor; Hamid Zahednasab; Mohammad Farahmand; Rasoul Mirzaei; Farhad Zamani; Alireza Tabibzadeh; Behnaz Bouzari; Hossein Ajdarkosh; Mehdi Nikkhah; Melika Razavi Hashemi; Azadeh Laali; Hossein Keyvani
Journal:  Int Immunopharmacol       Date:  2021-04-17       Impact factor: 5.714

9.  Vitamin D3 Administration to Patients with Confirmed COVID-19.

Authors:  Jalil Rashedi; Behroz Mahdavi Poor; Mohammad Asgharzadeh
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.